Chemomab Therapeutics (CMMB) Share-based Compensation (2011 - 2023)
Chemomab Therapeutics' Share-based Compensation came in at $623,000 for FY2025, up 1.0% from $617,000 in FY2024.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Share-based Compensation (2011 - 2023) Analysis & Trends
Going back to FY2016, Chemomab Therapeutics' Share-based Compensation data covers 10 years.
- Share-based Compensation carries a five-year compound annual growth rate of 36.8% (FY2020 to FY2025).
- The five-year range for annual Share-based Compensation is $617,000 (FY2024) to $3.21 million (FY2022).
- Per Business Quant, earlier years put Share-based Compensation at $617,000 in FY2024 (-58.6%), $1.49 million in FY2023 (-53.6%), $3.21 million in FY2022 (+59.0%) and $2.02 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Chemomab Therapeutics | 6.82 Mn | -28.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 238,000.00 |
| Sep 30, 2023 | 130,000.00 |
| Jun 30, 2023 | 639,000.00 |
| Mar 31, 2023 | 484,000.00 |
| Dec 31, 2022 | 740,000.00 |
| Sep 30, 2022 | 836,000.00 |
| Jun 30, 2022 | 761,000.00 |
| Mar 31, 2022 | 874,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 441,000.00 |
| Jun 30, 2021 | 527,000.00 |
| Mar 31, 2021 | 43,000.00 |
| Dec 31, 2020 | 33,000.00 |
| Sep 30, 2020 | 23,000.00 |
| Jun 30, 2020 | 28,000.00 |
| Mar 31, 2020 | 46,000.00 |
| Dec 31, 2019 | 89,000.00 |
| Sep 30, 2019 | 321,000.00 |
| Jun 30, 2019 | 368,000.00 |
| Mar 31, 2019 | 380,000.00 |
API Access
Chemomab Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();